MoonLake Immunotherapeuti Valuation
| MLTX Stock | USD 51.86 2.04 4.09% |
At this time, the firm appears to be overvalued. MoonLake Immunotherapeuti secures a last-minute Real Value of $42.99 per share. The latest price of the firm is $51.86. Our model forecasts the value of MoonLake Immunotherapeuti from analyzing the firm fundamentals such as Return On Equity of -0.17, shares owned by insiders of 15.22 %, and Current Valuation of 2.65 B as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that MoonLake Immunotherapeuti's price fluctuation is very steady at this time. Calculation of the real value of MoonLake Immunotherapeuti is based on 3 months time horizon. Increasing MoonLake Immunotherapeuti's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since MoonLake Immunotherapeuti is currently traded on the exchange, buyers and sellers on that exchange determine the market value of MoonLake Stock. However, MoonLake Immunotherapeuti's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 51.86 | Real 42.99 | Hype 51.86 | Naive 48.09 |
The intrinsic value of MoonLake Immunotherapeuti's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence MoonLake Immunotherapeuti's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of MoonLake Immunotherapeutics helps investors to forecast how MoonLake stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of MoonLake Immunotherapeuti more accurately as focusing exclusively on MoonLake Immunotherapeuti's fundamentals will not take into account other important factors: MoonLake Immunotherapeuti Total Value Analysis
MoonLake Immunotherapeutics is now anticipated to have valuation of 2.65 B with market capitalization of 3.14 B, debt of 3.7 M, and cash on hands of 92.71 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the MoonLake Immunotherapeuti fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
2.65 B | 3.14 B | 3.7 M | 92.71 M |
MoonLake Immunotherapeuti Asset Utilization
One of the ways to look at asset utilization of MoonLake is to check how much profit was generated for every dollar of assets it reports. MoonLake Immunotherapeutics secures a negative usage of assets of -0.13 %, losing $0.001332 for each dollar of assets held by the firm. Inadequate asset utilization conveys that the company is being less effective with each dollar of assets it secures. Strictly speaking, asset utilization of MoonLake Immunotherapeutics shows how discouraging it operates for each dollar spent on its assets.MoonLake Immunotherapeuti Ownership Allocation
MoonLake Immunotherapeuti maintains a total of 63.06 Million outstanding shares. The majority of MoonLake Immunotherapeuti outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in MoonLake Immunotherapeutics to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in MoonLake Immunotherapeuti. Please pay attention to any change in the institutional holdings of MoonLake Immunotherapeuti as this could imply that something significant has changed or is about to change at the company. Also note that almost eight million four hundred twenty-five thousand three hundred thirty-seven invesors are currently shorting MoonLake Immunotherapeuti expressing very little confidence in its future performance.MoonLake Immunotherapeuti Profitability Analysis
Net Loss for the year was (44.08 M) with profit before overhead, payroll, taxes, and interest of 0.About MoonLake Immunotherapeuti Valuation
Our relative valuation model uses a comparative analysis of MoonLake Immunotherapeuti. We calculate exposure to MoonLake Immunotherapeuti's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of MoonLake Immunotherapeuti's related companies.MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. MoonLake Immunotherapeutics was founded in 2021 and is headquartered in Zug, Switzerland. Moonlake Immunotherapeuti is traded on NASDAQ Exchange in the United States.
MoonLake Immunotherapeuti Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 49.1 M |
Additional Tools for MoonLake Stock Analysis
When running MoonLake Immunotherapeuti's price analysis, check to measure MoonLake Immunotherapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MoonLake Immunotherapeuti is operating at the current time. Most of MoonLake Immunotherapeuti's value examination focuses on studying past and present price action to predict the probability of MoonLake Immunotherapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MoonLake Immunotherapeuti's price. Additionally, you may evaluate how the addition of MoonLake Immunotherapeuti to your portfolios can decrease your overall portfolio volatility.